{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:14:53Z","timestamp":1777900493797,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.gore.2026.102056","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:56:23Z","timestamp":1773042983000},"page":"102056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patient perspectives on post-operative direct oral anticoagulant for venous thromboembolism prevention in patients with gynecologic cancers undergoing laparotomy"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4662-4375","authenticated-orcid":false,"given":"Kristin A.","family":"Black","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Mateshaytis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sevick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Bisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Flasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Pin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gore.2026.102056_b0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","article-title":"A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS Project","volume":"243","author":"Agnelli","year":"2006","journal-title":"Ann. Surg."},{"key":"10.1016\/j.gore.2026.102056_b0010","doi-asserted-by":"crossref","unstructured":"Aletti G, Dowdy SC, Podratz KC, Cliby W. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 2007;197(6):676.e1-7. doi:10.1016\/j.ajog.2007.10.495.","DOI":"10.1016\/j.ajog.2007.10.495"},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.54352","article-title":"Risk of venous thromboembolic events after surgery for cancer","volume":"7","author":"Bj\u00f6rklund","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ijgc-2021-003006","article-title":"Use of direct oral anticoagulants for postoperative venous thromboembolism prophylaxis after surgery for gynecologic malignancies","volume":"32","author":"Boo","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.gore.2026.102056_b0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1477-7525-10-120","article-title":"The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients","volume":"10","author":"Cano","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.gore.2026.102056_b0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"4","key":"10.1016\/j.gore.2026.102056_b0035","first-page":"684","article-title":"A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis","volume":"75","author":"Clarke-Pearson","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gore.2026.102056_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2021.06.021","article-title":"Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism \u2013 the COSIMO study","volume":"206","author":"Cohen","year":"2021","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2020.07.096","article-title":"Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery","volume":"159","author":"Glickman","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0050","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in Nonorthopedic Surgical patients","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.gore.2026.102056_b0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: a Randomized Clinical Trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.gore.2026.102056_b0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2026.102056_b0065","doi-asserted-by":"crossref","unstructured":"Khorana AA, Dalal, Lin, Connolly. Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States. Clin Outcomes Res. Published online February 2013:10Doi:10.2147\/CEOR.S39964.","DOI":"10.2147\/CEOR.S39964"},{"issue":"3","key":"10.1016\/j.gore.2026.102056_b0070","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"26","key":"10.1016\/j.gore.2026.102056_b0075","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9717","key":"10.1016\/j.gore.2026.102056_b0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial","volume":"375","author":"Lassen","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.gore.2026.102056_b0085","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.thromres.2018.01.028","article-title":"Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer","volume":"164","author":"Lyman","year":"2018","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.gore.2026.102056_b0090","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/ijgc-2019-000284","article-title":"Patients\u2019 experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynecological cancer: a prospective observational study","volume":"29","author":"Marchocki","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.gore.2026.102056_b0095","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jso.26728","article-title":"Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: a multidisciplinary quality improvement project","volume":"125","author":"McGinnis","year":"2022","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2015.12.019","article-title":"Guidelines for postoperative care in gynecologic\/oncology surgery: Enhanced Recovery after Surgery (ERAS\u00ae) Society recommendations \u2014 Part II","volume":"140","author":"Nelson","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ygyno.2015.11.015","article-title":"Guidelines for pre- and intra-operative care in gynecologic\/oncology surgery: Enhanced Recovery after Surgery (ERAS\u00ae) Society recommendations \u2014 Part I","volume":"140","author":"Nelson","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102056_b0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2023.04.009","article-title":"Enhanced recovery after surgery (ERAS\u00ae) society guidelines for gynecologic oncology: addressing implementation challenges \u2013 2023 update","volume":"173","author":"Nelson","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.gore.2026.102056_b0115","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual. Saf."},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2012.11.027","article-title":"Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies","volume":"128","author":"Schmeler","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.gore.2026.102056_b0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.gore.2026.102056_b0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2020.04.696","article-title":"Patient reported outcomes measures in gynecologic oncology: a primer for clinical use, part I","volume":"158","author":"Sisodia","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.gore.2026.102056_b0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2020.03.022","article-title":"Patient reported outcomes measures in gynecologic oncology: a primer for clinical use","volume":"158","author":"Sisodia","year":"2020","journal-title":"Part II. Gynecol Oncol."},{"key":"10.1016\/j.gore.2026.102056_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2023.02.012","article-title":"Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy","volume":"172","author":"Sp\u00e9nard","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102056_b0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2024.06.013","article-title":"Avoiding the needle: a quality improvement program introducing apixaban for extended thromboprophylaxis after major gynecologic cancer surgery","volume":"188","author":"Stewart","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.gore.2026.102056_b0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","year":"2015","journal-title":"Transl. Behav. Med."},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055090","article-title":"Incidence, clinical characteristics and long-term prognosis of postoperative symptomatic venous thromboembolism: a retrospective cohort study","volume":"12","author":"Takeda","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.gore.2026.102056_b0160","doi-asserted-by":"crossref","first-page":"140.e1","DOI":"10.1016\/j.ajog.2023.04.045","article-title":"Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery","volume":"229","author":"Taylor","year":"2023","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:30:36Z","timestamp":1777631436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"alternative-id":["S2352578926000366"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102056","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient perspectives on post-operative direct oral anticoagulant for venous thromboembolism prevention in patients with gynecologic cancers undergoing laparotomy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102056"}}